IRIS
ROSELLI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 60.679
AS - Asia 7.404
EU - Europa 5.951
SA - Sud America 1.115
AF - Africa 99
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 15
Totale 75.289
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 60.470
SG - Singapore 3.685
CN - Cina 1.392
IT - Italia 987
BR - Brasile 926
DE - Germania 884
RU - Federazione Russa 853
UA - Ucraina 769
HK - Hong Kong 635
IE - Irlanda 635
VN - Vietnam 633
FR - Francia 450
GB - Regno Unito 335
FI - Finlandia 279
KR - Corea 271
PL - Polonia 251
JP - Giappone 210
SE - Svezia 188
IN - India 141
CA - Canada 108
NL - Olanda 106
ID - Indonesia 89
AR - Argentina 74
BD - Bangladesh 66
MX - Messico 61
IQ - Iraq 49
AT - Austria 43
ES - Italia 40
EC - Ecuador 35
ZA - Sudafrica 34
BE - Belgio 30
TR - Turchia 30
PK - Pakistan 25
SA - Arabia Saudita 21
CO - Colombia 20
CZ - Repubblica Ceca 20
EU - Europa 19
MA - Marocco 18
PH - Filippine 18
CL - Cile 17
LT - Lituania 15
AU - Australia 14
EG - Egitto 14
PY - Paraguay 14
TW - Taiwan 14
AE - Emirati Arabi Uniti 13
MY - Malesia 13
UZ - Uzbekistan 13
VE - Venezuela 13
GR - Grecia 11
RO - Romania 11
CH - Svizzera 10
CR - Costa Rica 9
JM - Giamaica 9
KE - Kenya 9
TH - Thailandia 9
IR - Iran 8
AL - Albania 7
AZ - Azerbaigian 7
HN - Honduras 7
KG - Kirghizistan 7
PE - Perù 7
JO - Giordania 6
KZ - Kazakistan 6
NP - Nepal 6
PT - Portogallo 6
UY - Uruguay 6
DZ - Algeria 5
IL - Israele 5
OM - Oman 5
TN - Tunisia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
NO - Norvegia 4
QA - Qatar 4
BG - Bulgaria 3
LB - Libano 3
MN - Mongolia 3
RS - Serbia 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
A1 - Anonimo 2
AO - Angola 2
BH - Bahrain 2
BZ - Belize 2
CI - Costa d'Avorio 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
KW - Kuwait 2
LK - Sri Lanka 2
NG - Nigeria 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
Totale 75.270
Salva come PNG Salva come JPEG
Città #
Woodbridge 16.857
Wilmington 15.438
Houston 14.798
Singapore 1.798
Fairfield 1.669
Ashburn 1.144
Ann Arbor 1.013
Chandler 831
Seattle 694
San Jose 692
Jacksonville 682
Cambridge 632
Hong Kong 621
Dublin 569
Beijing 520
Medford 432
Rome 345
Santa Clara 314
Dearborn 287
The Dalles 284
New York 276
Council Bluffs 248
Kraków 215
Ho Chi Minh City 199
Lawrence 199
Los Angeles 195
Tokyo 173
Hanoi 160
Dallas 157
Buffalo 148
Lauterbourg 146
Moscow 143
San Diego 139
Menlo Park 122
Helsinki 100
Zhengzhou 96
Orem 87
São Paulo 83
Chicago 82
Milan 79
Engelhard 73
London 61
Jakarta 60
Mülheim 56
Nuremberg 53
Saint Petersburg 49
Boardman 48
Redondo Beach 47
Falls Church 46
Chennai 44
Nanjing 40
Phoenix 39
Montreal 38
Norwalk 37
Shanghai 37
Guangzhou 35
Munich 35
Hefei 34
Redwood City 34
Salt Lake City 33
North Bergen 31
Warsaw 31
Brussels 30
Frankfurt am Main 29
Detroit 28
Rio de Janeiro 28
Amsterdam 27
Brooklyn 27
Porto Alegre 27
Denver 26
Manchester 26
Mountain View 26
Boston 24
Da Nang 24
Lappeenranta 24
Toronto 24
Columbus 23
Kunming 23
University Park 23
Hangzhou 21
Verona 21
Curitiba 20
Palo Alto 20
Belo Horizonte 19
Mexico City 19
Mumbai 19
Seoul 19
Tampa 19
Atlanta 18
Johannesburg 18
Turin 17
Dong Ket 16
Elk Grove Village 16
Haiphong 16
Miami 16
Nürnberg 16
Poplar 16
Stockholm 16
Vienna 16
Biên Hòa 15
Totale 64.440
Salva come PNG Salva come JPEG
Nome #
Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers 666
Soluble selectin levels in patients with lung cancer 620
Role of serum and glucocorticoid-inducible kinase (SGK)-1 in senescence: a novel molecular target against age-related diseases 546
Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma 543
Sex-Genetic Interaction in the Risk for Cerebrovascular Disease 529
Pharmacogenomics and pharmacogenetics of thiazolidinediones: Role in diabetes and cardiovascular risk factors 524
Postoperative adjuvant therapy for stage IB non-small-cell lung cancer 520
Sample PREanalytical Code for labeling of biospecimens: an analysis of specimen labeling protocols 493
Anti-angiogenic drugs, vascular toxicity and thromboembolism in solid cancer 493
Angiogenesis and hypertension: the dual role of anti-hypertensive and anti-angiogenic therapies 484
Aging: an important risk factor in chemotherapy-associated vascular diseases 478
The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study 477
Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patients 472
Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care) 471
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors 470
Spontaneous immunogenicity of ribosomal P0 protein in patients with benign and malignant breast lesions and delay of mammary tumor growth in P0-vaccinated mice 468
Minimal sentinel node procedure for staging early breast cancer 467
Increased risk of chemotherapy-associated venous thromboembolism in elderly patients with cancer 467
Pathological classification of DCIS and planning of therapeutic management 466
Adjuvant chemotherapy for stage IB non-small cell lung cancer 466
Impact of endoscopic ultrasound-guided fine-needle aspiration and multidisciplinary approach in the management of abdominal or mediastinal mass 466
Butyryl-cholinesterase is related to muscle mass and strength. A new biomarker to identify elderly subjects at risk of sarcopenia 465
Ketogenic diet and other dietary intervention strategies in the treatment of cancer 463
Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer 463
Predictive value of high-sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients 462
Effects of conventional therapeutic interventions on the number and function of regulatory T cells 460
Biological and predictive role of ERCC1 polymorphisms in cancer 460
Functional impairment of activated protein C in breast cancer - relationship to survival outcomes 459
RISK: A random optimization interactive system based on kernel learning for predicting breast cancer disease progression 459
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies 457
Clinical models and biochemical predictors of VTE in lung cancer 457
Day-surgical management of ductal carcinoma in situ (DCIS)of the breast using wide local excision with sentinel node biopsy 455
Risk assessment for venous thromboembolism in chemotherapy treated ambulatory cancer patients: a machine learning approach 455
An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy 453
Immune reaction and colorectal cancer: friends or foes? 451
Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients--a pilot study 451
TNF-α gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy 451
Sentinel lymphadenectomy in cutaneous melanoma 451
Prognostic value of glycated hemoglobin in colorectal cancer 451
Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy 450
Cardiac surgery with extracorporeal circulation in cancer patients: risk factors for late survival and cancer-related event-free survival 449
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 449
Type 2 diabetes and breast cancer: The interplay between impaired glucose metabolism and oxidant stress 448
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 448
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients 447
Obesity and colorectal cancer: role of adipokines in tumor initiation and progression 446
RFID as a new ICT tool to monitor specimen life cycle and quality control in a biobank 446
Comparative studies between in vitro and in vivo effects of human beta-interferon on natural killer activity and its relevance to immunochemotherapy 445
A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer 445
Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101) 443
Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients 443
Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancer 440
Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients 440
Thromboembolic events in patients treated with anti-angiogenic drugs 437
Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesis 436
Are there alternative ways to quantify the real benefit of novel agents in oncology? - The 'death pace' 434
Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients 433
Prognostic value of pre-surgical plasma PAI-1 (plasminogen activator inhibitor-1) levels in breast cancer 432
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients 429
Chemoprevention of colonic cancer: is there a foreseeable future? 429
Monoclonal antibodies in gastrointestinal cancers 428
Rehabilitation in neuro-oncology: a meta-analysis of published data and a mono-institutional experience 428
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer 427
Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression 426
The value of soluble selectin levels in the management of lung cancer patients 425
Family history of cancer in patients with gastric cancer 424
Determinants of homocysteine levels in colorectal and breast cancer patients 422
Prognostic value of soluble P-selectin levels in colorectal cancer 421
Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: Pros and cons 421
A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice 419
Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention 419
Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis 418
Prognostic value of vascular endothelial growth factor tumor tissue content of colorectal cancer 417
VEGF and VTE risk in cancer patients-letter 417
The Medical Care Continuity (MCC) project. A pilot study of video-assisted home care within the eTEN European Community program. The Italian experience 416
VEGF gene promoter polymorphisms and risk of VTE in chemotherapytreated cancer patients 416
Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')2 (FO23C5) in CEA serum-negative colorectal cancer patients 415
Insulinemia and the risk of breast cancer and its relapse 415
Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer 415
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study 413
Postoperative adjuvant therapy for stage IB non-small-cell lung cancer 411
Percutaneous cryoablation and vertebroplasty: a case report 411
CD26: a multi-purpose pharmacological target 411
Impact of chemotherapy on venous thromboembolism: comment to: regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study 410
Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro 410
Postsurgical chemotherapy in stage IB nonsmall cell lung cancer: Long-term survival in a randomized study 409
[Ductal carcinoma in situ (DCIS): an always present reality; which treatment? Role of sentinel lymph node] 409
Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle 408
Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer 407
Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis 406
The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy 405
In vivo comparison of CHX-DTPA ligand isomers in athymic mice bearing carcinoma xenografts 404
Radiofrequency Heat Ablation and Vertebroplasty in the treatment of neoplastic vertebral body fractures 403
The use of B72.3 second generation (CC) monoclonal antibody for the radioimmunolocalization of human carcinoma xenografts 403
Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial 402
Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapy 402
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 402
VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea 401
Mutational analysis of gastrointestinal stromal tumors (GISTs): procedural approach for diagnostic purposes 399
Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation 397
Totale 44.590
Salva come PNG Salva come JPEG
Categoria #
all - tutte 175.579
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.579
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021441 0 0 0 0 0 0 0 0 0 0 351 90
2021/20222.273 108 237 84 103 98 178 199 178 139 256 165 528
2022/20232.392 261 198 55 264 232 588 204 150 183 28 162 67
2023/20241.035 106 34 59 40 93 237 154 47 22 32 7 204
2024/20255.794 164 1.229 550 300 120 333 405 272 548 566 783 524
2025/20268.173 674 470 1.113 683 815 320 1.024 1.156 1.049 781 88 0
Totale 75.993